Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 18251127)

Published in Hepatogastroenterology on February 06, 2008

Authors

Hong Wu1, Lu-Nan Yan, Nan-Sheng Cheng, Yan-Ge Zhang, Chen-Guo Ker

Author Affiliations

1: Department of General Surgery, West China Hospital, Sichuan University, Chengdo, Sichuan, China.

Articles by these authors

The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33

Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.98

TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.84

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58

Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2007) 1.56

Giant submucosal lipoma located in the descending colon: a case report and review of the literature. World J Gastroenterol (2007) 1.52

Laparoscopic liver surgery for patients with hepatocellular carcinoma. Ann Surg Oncol (2007) 1.48

Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2015) 1.39

Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol (2005) 1.33

Two-stage vs single-stage management for concomitant gallstones and common bile duct stones. World J Gastroenterol (2012) 1.24

Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.19

Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol (2012) 1.07

Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation? Transplantation (2014) 1.07

Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol (2013) 1.02

Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma. Hepatogastroenterology (2004) 1.02

Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res (2008) 0.99

Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol (2012) 0.99

Basal cell carcinoma of the nipple-areola complex: a case report. Kaohsiung J Med Sci (2005) 0.98

Single-incision laparoscopic appendectomy vs conventional laparoscopic appendectomy: systematic review and meta-analysis. World J Gastroenterol (2013) 0.98

Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 0.94

Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol (2007) 0.94

Leptin in hepatocellular carcinoma. World J Gastroenterol (2010) 0.93

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett (2008) 0.93

The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. J Surg Oncol (2009) 0.92

Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol (2013) 0.92

Handlebar hernia with jejunal and duodenal injuries: a case report. Kaohsiung J Med Sci (2004) 0.91

Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.91

Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. World J Surg (2011) 0.90

Relationship between pancreaticobiliary maljunction and gallbladder carcinoma: meta-analysis. Hepatobiliary Pancreat Dis Int (2011) 0.89

UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol (2005) 0.89

Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89

Natural course of splenic artery aneurysm with associated spontaneous splenorenal shunt in non-cirrhotic liver: an 18-year observational follow-up and review of literature. Kaohsiung J Med Sci (2012) 0.89

Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.88

Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol (2003) 0.88

Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int (2004) 0.87

Changes of lipid metabolism in plasma, liver and bile during cholesterol gallstone formation in rabbit model. World J Gastroenterol (1998) 0.87

Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87

Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Hepatobiliary Pancreat Dis Int (2004) 0.87

TG13 miscellaneous etiology of cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 0.86

Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol (2004) 0.86

Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86

Orthotopic liver transplantation for patients with Caroli's disease. Hepatobiliary Pancreat Dis Int (2008) 0.86

Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: a systematic review and meta-analysis. HPB (Oxford) (2014) 0.85

Staging of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2003) 0.85

The impact of body mass index on laparoscopic cholecystectomy in Taiwan: an oriental experience. J Hepatobiliary Pancreat Surg (2009) 0.85

 Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol (2012) 0.84

Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol (2012) 0.84

Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.84

Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol (2003) 0.84

Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol (2009) 0.83

Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology (2012) 0.83

Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int (2009) 0.83

Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists. Hepatobiliary Pancreat Dis Int (2012) 0.83

Caudate lobectomy by the third porta hepatis anatomical method: a study of 16 cases. Hepatobiliary Pancreat Dis Int (2006) 0.83

Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation. Hepatogastroenterology (2012) 0.82

Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis. World J Gastroenterol (1999) 0.82

Liver transplantation for patients with hepatolithiasis. Hepatobiliary Pancreat Dis Int (2005) 0.82

CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Ann Surg Oncol (2009) 0.82

Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. Asian J Surg (2004) 0.82

Inadequate energy delivery during early critical illness correlates with increased risk of mortality in patients who survive at least seven days: a retrospective study. Clin Nutr (2010) 0.82

A successful pregnancy following liver transplantation. Hepatobiliary Pancreat Dis Int (2007) 0.82

Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol (2004) 0.82

Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study. Carcinogenesis (2007) 0.81

Treatment of hepatic venous outflow stenosis after living donor liver transplantation by insertion of an expandable metallic stent. Hepatobiliary Pancreat Dis Int (2009) 0.81

One-stage versus two-stage management for concomitant gallbladder stones and common bile duct stones in patients with obstructive jaundice. Am Surg (2013) 0.81

Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int (2006) 0.81

Safety of living donor liver transplantation using older donors. J Surg Res (2012) 0.81

Delayed internal pancreatic fistula with pancreatic pleural effusion postsplenectomy. World J Gastroenterol (2010) 0.81

Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol (2010) 0.81

Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol (2012) 0.80

An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence. Medicine (Baltimore) (2016) 0.80

Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol (2010) 0.80

Risks faced by donors of right lobe for living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2009) 0.80

Efficacy of ondansetron vs. metoclopramide in prophylaxis of postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Hepatogastroenterology (2012) 0.80

Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population. Cancer Sci (2007) 0.80

Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int (2007) 0.80

Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res (2007) 0.80

Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary Pancreat Dis Int (2003) 0.80

Laparoscopic cholecystectomy in aged patients. Hepatogastroenterology (2009) 0.80

Problems in adult living donor liver transplantation using the right hepatic lobe. Hepatobiliary Pancreat Dis Int (2006) 0.79

Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors. Hepatobiliary Pancreat Dis Int (2011) 0.79

Cavoportal hemitransposition in liver transplantation: a new technique. Hepatobiliary Pancreat Dis Int (2003) 0.79

Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology (2011) 0.79

Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases. J Cancer Res Clin Oncol (2014) 0.79

Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Hepatobiliary Pancreat Dis Int (2006) 0.79

Decreased retinol binding protein 4 concentrations are associated with cholesterol gallstone disease. J Formos Med Assoc (2010) 0.79

Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol (2012) 0.79

Zinc finger protein A20 promotes regeneration of small-for-size liver allograft and suppresses rejection and results in a longer survival in recipient rats. J Surg Res (2008) 0.79

Albumin and prealbumin may predict retinol status in patients with liver cirrhosis. Hepatogastroenterology (2008) 0.79

Improved early diagnosis of cystadenocarcinoma of the pancreas. Hepatobiliary Pancreat Dis Int (2007) 0.79

Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79

Carbon dioxide insufflation for endoscopic retrograde cholangiopancreatography: A meta-analysis and systematic review. World J Gastroenterol (2012) 0.79

Factors associated with early mortality after living-donor liver transplant. Exp Clin Transplant (2014) 0.78

Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC. Hepatobiliary Pancreat Dis Int (2016) 0.78